Back to company

NORDIC PHARMACEUTICALS ApS: Financial statements 2016

CVR: 27430015

NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,436,327 and a net result of DKK 144,883 compared with DKK 281,651 the year before. That is an increase of 10.9% compared with the year before. Equity amounted to DKK 1,188,763. The solvency ratio was 31.6%. The company had 3 employees in the financial year.

Gross Profit
1,436,327 kr.
Profit/Loss
144,883 kr.
Equity
1,188,763 kr.
Total Assets
3,759,061 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-1.4 mio.145 t.1.2 mio.3
2015-1.3 mio.282 t.1 mio.-
2014-899 t.152 t.762 t.-
2013-808 t.190 t.611 t.-
2012-959 t.421 t.614 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is NORDIC PHARMACEUTICALS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

NORDIC PHARMACEUTICALS ApS: The 2015 annual report is outJun 9, 2016

NORDIC PHARMACEUTICALS ApS has published its annual report for 2015. Gross profit came to DKK 1,295,706, and the net result was DKK 281,651.

NORDIC PHARMACEUTICALS ApS appoints new auditorJan 1, 2016

As of January 1, 2016, Revisionshuset Tal & Tanker Statsautoriseret Revisionspartnerselskab has been appointed auditor of NORDIC PHARMACEUTICALS ApS.

Auditor steps down at NORDIC PHARMACEUTICALS ApSJan 1, 2016

As of January 1, 2016, ONE REVISION A/S has stepped down as auditor of NORDIC PHARMACEUTICALS ApS.

About NORDIC PHARMACEUTICALS ApS

NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 3 employees. In 2024, the company reported a gross profit of DKK -2,243,265 and a net result of DKK -2,664,416 compared with DKK 9,351 the year before. Equity amounted to DKK -1,152,541.